# An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

> **NCT00092170** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 100 (—)

## Conditions studied

- Infections
- Pelvic Infections

## Interventions

- **DRUG:** MK0826, ertapenem sodium
- **DRUG:** Comparator: Ticarcillin/Clavulanate

## Key facts

- **NCT ID:** NCT00092170
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2004-01
- **Final completion:** 2004-01
- **Target enrollment:** 100 (—)
- **Last updated:** 2017-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092170, "An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00092170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*